Tenjarla Srini 4
4 · Serina Therapeutics, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Tenjarla Srini
SVP, CMC & Formulation
Transactions
- Award
Stock Option (right to buy)
2024-07-15+185,000→ 185,000 totalExercise: $9.50Exp: 2034-07-15→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]The stock options vest as to 61,666 of the underlying shares on July 15, 2025, and thereafter in substantially equal installments such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.